Clinical Trials of South Carolina has been selected as one of the only sites in the Southeast to work on a promising, Phase III vaccine study for COVID-19. Study participants must be healthy and negative for COVID-19 during screening. Patient enrollment is limited, as there is only a finite amount of the investigational vaccine in production. Study patients receive access to potential virus immunity, compensation for their time/travel and the opportunity to play a historic role in the advancement of medicine.
To learn more please call (843) 789-3707.